MENU
ACRV
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Acrivon Therapeutics (ACRV) Earnings Date & Reports
Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform... Show more
A.I. Advisor
published Earnings
ACRV is expected to report earnings to rise 4.65% to -44 cents per share on November 12
Q3'26
Est.
$-0.45
Q2'26
Beat
by $0.21
Q1'26
Beat
by $0.13
Q4'25
Beat
by $0.72
Q3'25
Beat
by $0.69
The last earnings report on August 12 showed earnings per share of -43 cents, beating the estimate of -63 cents. With 150.25K shares outstanding, the current market capitalization sits at 68.99M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Related Blogs
Interesting Articles
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Industry
N/A
Address
480 Arsenal Way
Phone
+1 617 207-8979
Employees
76
Web
https://www.acrivon.com